DMH-25
DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.
Product Specifications
CAS Number
1685280-21-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
489.94
Molecular Formula
C15H8Br3NO3
Notes
Research use only, not for human use.
Receptor
MTOR
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
